ATE99945T1 - Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln. - Google Patents

Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.

Info

Publication number: ATE99945T1
Authority: AT; Austria
Prior art keywords: deoxy; seborrhea; reduce; salts; methylthioadenosin
Prior art date: 1989-03-13

Application number

AT90104640T

Other languages

English (en)

Inventor

Moratti Emanuela Maggioni

Original Assignee

Bioresearch Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-13

Filing date

1990-03-12

Publication date

1994-01-15

1990-03-12 Application filed by Bioresearch Spa filed Critical Bioresearch Spa

1994-01-15 Application granted granted Critical

1994-01-15 Publication of ATE99945T1 publication Critical patent/ATE99945T1/de

Links

206010039792 Seborrhoea Diseases 0.000 title abstract 2
208000008742 seborrheic dermatitis Diseases 0.000 title abstract 2
QBTUGZFWEOWLGR-NBJNCIKXSA-N CC[C@H]([C@H]([C@H]1S)O)O[C@H]1N1C2=NC=NC(N)=C2N=C1.C[S+](CC[C@@H](C([O-])=O)N)C[C@H]([C@H]([C@H]1O)O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 Chemical compound CC[C@H]([C@H]([C@H]1S)O)O[C@H]1N1C2=NC=NC(N)=C2N=C1.C[S+](CC[C@@H](C([O-])=O)N)C[C@H]([C@H]([C@H]1O)O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QBTUGZFWEOWLGR-NBJNCIKXSA-N 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
208000003251 Pruritus Diseases 0.000 abstract 1
MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 abstract 1
206010040844 Skin exfoliation Diseases 0.000 abstract 1
229960001570 ademetionine Drugs 0.000 abstract 1
230000035618 desquamation Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
210000004761 scalp Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/008—Preparations for oily hair
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Birds (AREA)
Biotechnology (AREA)
Dermatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

AT90104640T 1989-03-13 1990-03-12 Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln. ATE99945T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT8919737A IT1229477B (it)	1989-03-13	1989-03-13	Impiego di 5' deossi - 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative

Publications (1)

Publication Number	Publication Date
ATE99945T1 true ATE99945T1 (de)	1994-01-15

Family

ID=11160803

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90104640T ATE99945T1 (de)	1989-03-13	1990-03-12	Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.

Country Status (11)

Country	Link
US (1)	US5753213A (de)
EP (1)	EP0387756B1 (de)
JP (1)	JPH0778011B2 (de)
KR (1)	KR900013969A (de)
AT (1)	ATE99945T1 (de)
CA (1)	CA2012046C (de)
DE (1)	DE69005860T2 (de)
DK (1)	DK0387756T3 (de)
ES (1)	ES2062137T3 (de)
IT (1)	IT1229477B (de)
ZA (1)	ZA901929B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1247903B (it) *	1991-02-25	1995-01-05	Bioresearch Spa	Impiego della s-adenosil-l-metionina nel trattamento della colestasi intraepatica da nutrizione parenterale totale
KR100309141B1 (ko) *	1998-04-13	2001-12-28	조영동	5'-데옥시-5'-메틸티오아데노신을이용한면역분석방법
DE10132338A1 (de) *	2001-07-04	2003-01-16	Basf Ag	Verwendung von 5'-Desoxy-5'-methylthioadenosin in hautkosmetischen Mitteln
ITMI20012462A1 (it) *	2001-11-22	2003-05-22	Gnosis Srl	Processo per la preparazione di compresse comprendenti s-adenosilmetionina
ITMI20032393A1 (it) *	2003-12-05	2005-06-06	Applied Pharma Res	Composizioni contenenti metilioadenosina-mta-e loro uso topico.
US7406746B2 (en) *	2004-08-31	2008-08-05	Bushey Richard D	Slider for heavy loads
FR2884421B1 (fr)	2005-04-15	2007-08-10	Virbac Sa	Nouveaux moyens de regulation des troubles du comportement chez les animaux de compagnie
WO2006111541A2 (en) *	2005-04-20	2006-10-26	Basf Plant Science Gmbh	Expression cassettes for seed-preferential expression in plants
AU2008210327B2 (en) *	2007-01-31	2011-06-16	Methylation Sciences International Srl	Extended release pharmaceutical formulations of S-adenosylmethionine
US20090088404A1 (en) *	2007-01-31	2009-04-02	Methylation Sciences International Srl	Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20100062993A1 (en) *	2008-09-11	2010-03-11	Yochanan R. Bulka	Adenosine Nucleotides as Dietary Supplements and as Agents in the Prevention of Cancer and the Metastasis Thereof
US8329208B2 (en)	2009-07-28	2012-12-11	Methylation Sciences International Srl	Pharmacokinetics of S-adenosylmethionine formulations
US20110027342A1 (en) *	2009-07-28	2011-02-03	Msi Methylation Sciences, Inc.	S-adenosylmethionine formulations with enhanced bioavailability
ES2540581T3 (es)	2012-10-17	2015-07-10	Methylation Sciences International Srl	Composiciones que comprenden S-adenosilmetionina y un éster de ácido gálico
JP6226962B2 (ja) *	2013-04-05	2017-11-08	ライオン株式会社	ノンレム睡眠促進剤、深睡眠促進剤、自然睡眠誘発剤、および睡眠初期デルタパワー向上剤
AU2024274445A1 (en)	2023-05-15	2025-11-27	Bonafide Health, Llc	Sleep-improving compositions and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA7464B (en) *	1973-01-16	1974-11-27	J Voorhees	Treatment of proliferating skin diseases with papavine alkaloids
AR221676A1 (es) *	1974-07-12	1981-03-13	Bioresearch Sas	Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4496588A (en) *	1977-07-11	1985-01-29	Merrell Toraude Et Compagnie	Method of treating psoriasis
US4373097A (en) *	1981-04-27	1983-02-08	Bioresearch S.R.L.	Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity
IT1137640B (it) *	1981-08-24	1986-09-10	Bioresearch Srl	Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
JPS59134710A (ja) *	1983-01-21	1984-08-02	Suntory Ltd	発酵養毛化粧料
FR2580478B1 (fr) *	1985-04-17	1989-05-12	Christian Chapoton	Dispositif de traitement capillaire liberant une substance active et procede de fabrication
EP0216357A3 (de) *	1985-09-25	1988-08-31	Nippon Zeon Co., Ltd.	Phosphoramidit-Verbindungen und Verfahren zu deren Herstellung
GB8607265D0 (en) *	1986-03-24	1986-04-30	London King S College	Protecting groups of organic synthesis
WO1988004301A1 (fr) *	1986-12-02	1988-06-16	Centre National De La Recherche Scientifique (Cnrs	OLIGONUCLEOTIDES alpha
FR2623396B1 (fr) *	1987-11-25	1990-03-30	Sanofi Sa	Utilisation de l'ademetionine contre le vieillissement de la peau

1989
- 1989-03-13 IT IT8919737A patent/IT1229477B/it active
1990
- 1990-03-12 AT AT90104640T patent/ATE99945T1/de not_active IP Right Cessation
- 1990-03-12 DK DK90104640.9T patent/DK0387756T3/da active
- 1990-03-12 EP EP90104640A patent/EP0387756B1/de not_active Expired - Lifetime
- 1990-03-12 DE DE90104640T patent/DE69005860T2/de not_active Expired - Lifetime
- 1990-03-12 ES ES90104640T patent/ES2062137T3/es not_active Expired - Lifetime
- 1990-03-12 KR KR1019900003230A patent/KR900013969A/ko not_active Ceased
- 1990-03-13 US US07/492,991 patent/US5753213A/en not_active Expired - Fee Related
- 1990-03-13 JP JP2060126A patent/JPH0778011B2/ja not_active Expired - Fee Related
- 1990-03-13 ZA ZA901929A patent/ZA901929B/xx unknown
- 1990-03-13 CA CA002012046A patent/CA2012046C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0387756A1 (de)	1990-09-19
DE69005860D1 (de)	1994-02-24
JPH0778011B2 (ja)	1995-08-23
DK0387756T3 (da)	1994-03-07
CA2012046C (en)	2001-02-13
IT8919737A0 (it)	1989-03-13
KR900013969A (ko)	1990-10-22
ZA901929B (en)	1990-12-28
EP0387756B1 (de)	1994-01-12
CA2012046A1 (en)	1990-09-13
US5753213A (en)	1998-05-19
IT1229477B (it)	1991-09-03
JPH0368520A (ja)	1991-03-25
ES2062137T3 (es)	1994-12-16
DE69005860T2 (de)	1994-04-28

Similar Documents

Publication	Publication Date	Title
ATE99945T1 (de)	1994-01-15	Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.
DE3883035D1 (de)	1993-09-16	Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
DE3688114D1 (de)	1993-04-29	Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
AU4732989A (en)	1990-07-05	Pyrimidines and their pharmaceutical acceptable salts thereof, and their use as medicines
AU637086B2 (en)	1993-05-20	Use of 5-methyltetrahydrofolic acid, 5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled- release form active in the therapy of organic mental disturbances, and the relative pharmaceutical compositions
FI862011A0 (fi)	1986-05-14	Terapeutiska nukleosider.
GR3007790T3 (de)	1993-08-31
EE9600019A (et)	1996-08-15	2,8-diasendatud kinasolinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
NL970006I1 (nl)	1997-04-01	Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
ATE231863T1 (de)	2003-02-15	6-amino-purinderivate mit pde-iv inhibierender wirkung
ES2037086T3 (es)	1993-06-16	Procedimiento para preparar formulaciones farmaceuticas.
CY1786A (en)	1995-10-20	Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety
GEP20043162B (en)	2004-01-26	Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
ATE107168T1 (de)	1994-07-15	Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
ES555118A0 (es)	1988-07-16	Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
ATE110269T1 (de)	1994-09-15	Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
DE69005160D1 (de)	1994-01-27	Verwendung von 5'-Deoxy-5'-methylthioadenosin, s-Adenylmethionin und deren Salzen zur Herstellung pharmazeutischer Präparate zur Förderung des Haarwuchses bei Patienten mit Kahlköpfigkeit.
IT8920358A0 (it)	1989-05-03	Impiego di derivati della fosfatidil carnitina per la preparazione di composizioni farmaceutiche aventi attivita' nella terapia delle patologie dell'uomo associate con un danno neuronale.
ITMI911445A1 (it)	1992-11-28	Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
DE3773716D1 (de)	1991-11-21	Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
IT8821570A0 (it)	1988-07-29	Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
ATE133177T1 (de)	1996-02-15	3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
HUT71838A (en)	1996-02-28	Use of biologically active ureido derivatives useful in the treatment of lentivirus-induced disease for producing pharmaceutical compositions
EP0301239A3 (en)	1990-10-10	Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
SE8802323D0 (sv)	1988-06-21	8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it

Legal Events

Date	Code	Title
1994-10-15	UEP	Publication of translation of european patent specification
2000-07-15	EEIH	Change in the person of patent owner
2003-06-15	EEFA	Change of the company name
2010-06-15	EELA	Cancelled due to lapse of time